Key result
This review highlights the role of cyclooxygenase inhibitors in cardiovascular homeostasis, arterial thrombosis, and how cox-1 genetic variations impact aspirin sensitivity and cardiovascular risk.
Design
Review
Authors
Loading...
May guide aspirin nonresponder identification via COX-1 variants; leaves open prospective outcome trials before practice change.
Understanding cyclooxygenase pathways and genetic variants in COX-1 may help identify patients susceptible to aspirin resistance or side effects, guiding safer antithrombotic therapies.
Bunimov et al. (2008) conducted a review in Cardiovascular homeostasis and arterial thrombosis. Cyclooxygenase inhibitors (Aspirin, NSAIDs, Coxibs) was evaluated. This review highlights the role of cyclooxygenase inhibitors in cardiovascular homeostasis, arterial thrombosis, and how cox-1 genetic variations impact aspirin sensitivity and cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: